ReviewNature reviews. Clinical oncology2022
Tumour burden and efficacy of immune-checkpoint inhibitors.
Filippo G Dall'Olio et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
222 papers cite itlatest 60 shown
this paperpooled ittrialcites it